RISK FACTORS AND COMORBIDITY IN PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE

Yuliia Kushnir

Abstract


The aim of the study was to evaluate the risk factors and the incidence of comorbidity in patients with coronary heart disease, depending on the presence of atrial fibrillation.

Materials and methods of research: a retrospective analysis of 222 stories of illnesses of patients with coronary heart disease who undergo inpatient treatment, aged from 39 to 88 years, has been conducted. Depending on the presence of atrial fibrillation, all patients were divided into 2 groups: group 1 (main) - patients with ischemic heart disease with atrial fibrillation (n = 105), group 2 (comparison) - patients with ischemic heart disease without atrial fibrillation (n = 117).

Results. In the group of patients without AF, the proportion of persons with inherited exacerbations of IHD was 64.29 %, while in the main group - 25.0 %, the differences did not reach the statistically significant level, but this relationship is confirmed by the results of the rank correlation analysis - between the presence AP and heredity revealed a significant weak feedback - c=-0.21 (p<0.05). The diseases that were observed in the examined patients with coronary artery disease present acute violation of cerebral circulation, angina pectoris, acute myocardial infarction, hypertension, diabetes, pathology of the kidneys and the thyroid gland, diastolic dysfunction and obesity. The groups differed in the proportion of patients with stroke - in the group with AF, it was significantly (p=0.002) higher - 23.81 %, in compare to 8.55 % in the comparison group.

Conclusions: The presence of atrial fibrillation in patients with coronary heart disease is associated with a high degree of comorbidity. First of all, with the combination of IHD and atrial fibrillation, a high incidence of hypertension, diabetes mellitus, obesity, acute cerebrovascular disorder, kidney disease and thyroid gland is established.


Keywords


atrial fibrillation; ischemic heart disease; comorbid pathology; risk factors

Full Text:

PDF

References


Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J. et. al. (2014). Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation, 129 (8), 837–847. doi: 10.1161/circulationaha.113.005119

Oldgren, J., Healey, J. S., Ezekowitz, M., Commerford, P., Avezum, A. et. al. (2014). Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries: The RE-LY Atrial Fibrillation Registry. Circulation, 129 (15), 1568–1576. doi: 10.1161/circulationaha.113.005451

Maggioni, A. P. (2015). Epidemiology of Heart Failure in Europe. Heart Failure Clinics, 11 (4), 625–635. doi: 10.1016/j.hfc.2015.07.015

Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D. et. al. (2015). 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet, 386 (9989), 154–162. doi: 10.1016/s0140-6736(14)61774-8

Vanassche, T., Lauw, M. N., Eikelboom, J. W., Healey, J. S., Hart, R. G., Alings, M. et. al. (2014). Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. European Heart Journal, 36 (5), 281–288. doi: 10.1093/eurheartj/ehu307

Kuryata, О., Kushnir, Yu. (2014). Dynamics of aldosterone levels in patients with chronic heart failure with preserved ejection fraction under the influence of treatment. Meditsina-neotlozhnyh-sostoyani, 2, 57–62.

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C. et. al. (2014). 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 130 (23), e199–e267. doi: 10.1161/cir.0000000000000041

Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A. et. al. (2012). Subclinical Atrial Fibrillation and the Risk of Stroke. New England Journal of Medicine, 366 (2), 120–129. doi: 10.1056/nejmoa1105575

Kushnir, Yu. (2014). Hemodynamics, functional state of endothelium and renal function, platelets depending on the body mass index in patients with chronic heart failure and preserved systolic function. Medicni perspektivi, ХІХ (1), 29–36.

Kuryata, О., Kushnir, Yu. (2014). Body mass and aldosteron, leptin levels in patients with chronic heart failure and preserved ejection fraction. Suchasni medichni tehnologii, 1, 12–16.

Rebrova, O. (2006). Statistical analysis of medical data. Application of software package STATISTICA. Moscow: Mediasfera, 312.

Rebrova, О. (2002). Statistical analysis of medical data. Application of software package STATISTICA. Мoscow: MediaSfera, 312.

Salamanca-Bautista, P., Conde-Martel, A., Aramburu-Bodas, O., Formiga, F., Trullas, J. C., Quesada-Simon, M. A. et. al. (2016). Precipitating factors of heart failure admission: Differences related to age and left ventricular ejection fraction. International Journal of Cardiology, 219, 150–155. doi: 10.1016/j.ijcard.2016.06.040

Fleg, J. L., Strait, J. (2011). Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease. Heart Failure Reviews, 17 (4-5), 545–554. doi: 10.1007/s10741-011-9270-2

Kushnir, Yu. S., Kuryata, O. V., Dobrogorska, H. O. (2017). Cardiovascular diseases and comorbidity in patients with chronic heart failure and preserved ejection fraction depending on age. Simiina medycyna, 5 (73), 66–69.

Mitrousi, K., Lip, G. Y. H., Apostolakis, S. (2013). Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants. Journal of Atrial Fibrillation, 6 (1), 783.

Rizos, T., Horstmann, S., Dittgen, F., Tager, T., Jenetzky, E., Heuschmann, P., Veltkamp, R. (2016). Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke. Stroke, 47 (2), 336–341. doi: 10.1161/strokeaha.115.011465

Chen, X., Lin, M., Wang, W. (2017). The progression in atrial fibrillation patients with COPD: a systematic review and meta-analysis. Oncotarget, 8 (60), 102420–102427. doi: 10.18632/oncotarget.22092

Chang, V. W., Langa, K. M., Weir, D., Iwashyna, T. J. (2017). The obesity paradox and incident cardiovascular disease: A population-based study. PLOS ONE, 12 (12), e0188636. doi: 10.1371/journal.pone.0188636

Rizos, T., Horstmann, S., Dittgen, F., Tager, T., Jenetzky, E., Heuschmann, P., Veltkamp, R. (2016). Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke. Stroke, 47 (2), 336–341. doi: 10.1161/strokeaha.115.011465

Sposato, L. A., Riccio, P. M., Hachinski, V. (2014). Poststroke atrial fibrillation: Cause or consequence?: Critical review of current views. Neurology, 82 (13), 1180–1186. doi: 10.1212/wnl.0000000000000265

Kamel, H., Okin, P. M., Elkind, M. S., Iadecola, C. (2016). Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke, 47, 895–900. doi: 10.1161/strokeaha.115.012004

Bridge, F., Thijs, V. (2016). How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices. Journal of Stroke, 18 (2), 121–128. doi: 10.5853/jos.2016.00150

Nattel, S., Harada, M. (2014). Atrial Remodeling and Atrial Fibrillation. Journal of the American College of Cardiology, 63 (22), 2335–2345. doi: 10.1016/j.jacc.2014.02.555




DOI: http://dx.doi.org/10.21303/2504-5679.2018.00553

Refbacks

  • There are currently no refbacks.




Copyright (c) 2018 Yuliia Kushnir

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)